Skip to main content

Migraine

Hightower’s research has contributed to a deeper understanding and improved management of migraine headaches.

                       

Study About Migraine Headaches

Millions worldwide experience the debilitating effects of migraine. These severe headaches can cause throbbing pain, nausea, sensitivity to light and sound, and significantly disrupt daily life. While current treatments offer some relief, the search for more effective solutions continues.

Hightower Clinical actively manage clinical trials for migraine, exploring innovative approaches such as preventative oral medications and inhalation therapies and assessing the safety and effectiveness of participants suffering from difficult-to-treat migraine.

Current Status

Not Recruiting

Study Count

3

Study Information

Organized Clinical Trials of Migraine

Study NameProtocol NumberSponsor
MigraineBHV3500-302Biohaven
I5Q-MC-B004Eli Lilly and Company
STS101-007Satsuma Pharmaceuticals, Inc.

Frequently Asked Questions

How do migraine clinical trials contribute to migraine research and treatment?

Clinical trials are crucial in advancing our understanding of migraine, including its underlying mechanisms, triggers, and potential treatment approaches. By evaluating the safety and efficacy of new medications, devices, or behavioral interventions, these trials provide valuable insights into managing migraine and help identify novel therapeutic strategies.

Who is eligible to participate in migraine clinical trials?

Eligibility criteria for migraine clinical trials may vary depending on the specific focus and design of the study. Factors such as age, frequency and severity of migraine attacks, previous treatment history, comorbid medical conditions, and medication use may influence eligibility.

What should I expect if I participate in a migraine clinical trial?

Participation in a migraine clinical trial typically involves several steps, including screening for eligibility, providing informed consent, undergoing baseline assessments, and receiving the assigned treatment or intervention according to the trial protocol.